Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation.

Zhou Z, Hong EJ, Cohen S, Zhao WN, Ho HY, Schmidt L, Chen WG, Lin Y, Savner E, Griffith EC, Hu L, Steen JA, Weitz CJ, Greenberg ME.

Neuron. 2006 Oct 19;52(2):255-69.

2.

MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.

Kaufmann WE, Johnston MV, Blue ME.

Brain Dev. 2005 Nov;27 Suppl 1:S77-S87. Epub 2005 Sep 22. Review.

PMID:
16182491
3.

Regulation mechanism and research progress of MeCP2 in Rett syndrome.

Yang W, Pan H.

Yi Chuan. 2014 Jul;36(7):625-30. doi: 10.3724/SP.J.1005.2014.0625. Review.

PMID:
25076025
4.

The ups and downs of BDNF in Rett syndrome.

Sun YE, Wu H.

Neuron. 2006 Feb 2;49(3):321-3. Review.

5.

The role of MeCP2 in brain development and neurodevelopmental disorders.

Gonzales ML, LaSalle JM.

Curr Psychiatry Rep. 2010 Apr;12(2):127-34. doi: 10.1007/s11920-010-0097-7. Review.

6.

BDNF deregulation in Rett syndrome.

Li W, Pozzo-Miller L.

Neuropharmacology. 2014 Jan;76 Pt C:737-46. doi: 10.1016/j.neuropharm.2013.03.024. Epub 2013 Apr 15. Review.

7.

MeCP2 dysfunction in Rett syndrome and related disorders.

Moretti P, Zoghbi HY.

Curr Opin Genet Dev. 2006 Jun;16(3):276-81. Epub 2006 May 2. Review.

PMID:
16647848
8.

MeCP2 phosphorylation in the brain: from transcription to behavior.

Damen D, Heumann R.

Biol Chem. 2013 Dec;394(12):1595-605. doi: 10.1515/hsz-2013-0193. Review.

PMID:
23912219
9.

Brain-derived neurotrophic factor and Rett syndrome.

Katz DM.

Handb Exp Pharmacol. 2014;220:481-95. doi: 10.1007/978-3-642-45106-5_18. Review.

PMID:
24668484
10.

Rett syndrome: from the gene to the disease.

Matijevic T, Knezevic J, Slavica M, Pavelic J.

Eur Neurol. 2009;61(1):3-10. doi: 10.1159/000165342. Epub 2008 Oct 24. Review.

11.

MeCP2 and Rett syndrome: reversibility and potential avenues for therapy.

Gadalla KK, Bailey ME, Cobb SR.

Biochem J. 2011 Oct 1;439(1):1-14. doi: 10.1042/BJ20110648. Review.

PMID:
21916843
12.

The impact of MeCP2 loss- or gain-of-function on synaptic plasticity.

Na ES, Nelson ED, Kavalali ET, Monteggia LM.

Neuropsychopharmacology. 2013 Jan;38(1):212-9. doi: 10.1038/npp.2012.116. Epub 2012 Jul 11. Review.

13.

Rett syndrome: the complex nature of a monogenic disease.

Renieri A, Meloni I, Longo I, Ariani F, Mari F, Pescucci C, Cambi F.

J Mol Med (Berl). 2003 Jun;81(6):346-54. Epub 2003 May 16. Review.

PMID:
12750821
14.

The molecular pathology of Rett syndrome: synopsis and update.

Akbarian S, Jiang Y, Laforet G.

Neuromolecular Med. 2006;8(4):485-94. Review.

PMID:
17028371
15.

Rett syndrome and the impact of MeCP2 associated transcriptional mechanisms on neurotransmission.

Monteggia LM, Kavalali ET.

Biol Psychiatry. 2009 Feb 1;65(3):204-10. doi: 10.1016/j.biopsych.2008.10.036. Epub 2008 Dec 5. Review.

16.

In sickness and in health: the role of methyl-CpG binding protein 2 in the central nervous system.

Díaz de León-Guerrero S, Pedraza-Alva G, Pérez-Martínez L.

Eur J Neurosci. 2011 May;33(9):1563-74. doi: 10.1111/j.1460-9568.2011.07658.x. Epub 2011 Apr 1. Review.

17.

Autonomic dysfunction with mutations in the gene that encodes methyl-CpG-binding protein 2: insights into Rett syndrome.

Lioy DT, Wu WW, Bissonnette JM.

Auton Neurosci. 2011 Apr 26;161(1-2):55-62. doi: 10.1016/j.autneu.2011.01.006. Epub 2011 Feb 12. Review.

PMID:
21316312
18.

Mechanisms of disease: neurogenetics of MeCP2 deficiency.

Francke U.

Nat Clin Pract Neurol. 2006 Apr;2(4):212-21. Review.

PMID:
16932552
19.

Rett syndrome neuropathology review 2000.

Armstrong DD.

Brain Dev. 2001 Dec;23 Suppl 1:S72-6. Review.

PMID:
11738845
20.

Dendritic spine dysgenesis in Rett syndrome.

Xu X, Miller EC, Pozzo-Miller L.

Front Neuroanat. 2014 Sep 10;8:97. doi: 10.3389/fnana.2014.00097. eCollection 2014. Review.

Items per page

Supplemental Content

Write to the Help Desk